ES2075016T3 - La subunidad alfa del receptor de adherencia a leucocitos lfa-1. - Google Patents

La subunidad alfa del receptor de adherencia a leucocitos lfa-1.

Info

Publication number
ES2075016T3
ES2075016T3 ES89115160T ES89115160T ES2075016T3 ES 2075016 T3 ES2075016 T3 ES 2075016T3 ES 89115160 T ES89115160 T ES 89115160T ES 89115160 T ES89115160 T ES 89115160T ES 2075016 T3 ES2075016 T3 ES 2075016T3
Authority
ES
Spain
Prior art keywords
lfa
molecules
leukocytes
adherence
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89115160T
Other languages
English (en)
Inventor
Timothy Alan Springer
Richard Larson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dana Farber Cancer Institute Inc
Original Assignee
Dana Farber Cancer Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Institute Inc filed Critical Dana Farber Cancer Institute Inc
Application granted granted Critical
Publication of ES2075016T3 publication Critical patent/ES2075016T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

EL PRESENTE INVENTO SE REFIERE A LA SUBUNIDAD - ALFA LFA - 1 QUE ESTA INVOLUCRADA EN EL PROCESO A TRAVES DEL CUAL LA CELULA RECONOCE Y MIGRA HACIA LUGARES DE INFLAMACION ASI COMO SE SUJETA A SUBSTRATOS CELULARES DURANTE LAS INFLAMACIONES. EL INVENTO SE DIRIGE HACIA TALES MOLECULAS, LOS DERIVADOS FUNCIONALES DE TALES MOLECULAS, ENSAYOS PARA IDENTIFICAR TALES MOLECULAS Y USOS TERAPEUTICOS Y DIAGNOSTICOS PARA TALES MOLECULAS.
ES89115160T 1988-08-23 1989-08-17 La subunidad alfa del receptor de adherencia a leucocitos lfa-1. Expired - Lifetime ES2075016T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23522788A 1988-08-23 1988-08-23
US32101789A 1989-03-09 1989-03-09

Publications (1)

Publication Number Publication Date
ES2075016T3 true ES2075016T3 (es) 1995-10-01

Family

ID=26928699

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89115160T Expired - Lifetime ES2075016T3 (es) 1988-08-23 1989-08-17 La subunidad alfa del receptor de adherencia a leucocitos lfa-1.

Country Status (14)

Country Link
EP (1) EP0362526B1 (es)
JP (1) JPH02306999A (es)
KR (1) KR900002796A (es)
AT (1) ATE123810T1 (es)
AU (1) AU634974B2 (es)
DE (1) DE68923048T2 (es)
DK (1) DK412589A (es)
ES (1) ES2075016T3 (es)
FI (1) FI893916A7 (es)
GR (1) GR3017303T3 (es)
HU (1) HUT53673A (es)
IL (1) IL91369A (es)
NO (1) NO893366L (es)
PT (1) PT91503B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01502879A (ja) * 1987-02-26 1989-10-05 ダナ　ファーバー　キャンサー　インスティテュート Ｌｆａ―１のクローニング
US5395929A (en) * 1987-12-15 1995-03-07 Dana Farber Cancer Institute Isolated nucleic acid encoding the alpha subunit of the human leukocyte adhesion receptor
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
EP0362531B1 (en) 1988-09-01 1999-11-10 Bayer Corporation A human rhinovirus receptor protein that inhibits virus infectivity
WO1990010646A1 (en) * 1989-03-09 1990-09-20 Dana Farber Cancer Institute Leukocyte adhesion receptors
JPH04505009A (ja) * 1989-03-09 1992-09-03 ダナ・ファーバー・キャンサー・インスティチュート クローニングｌｆａ―１
DK0468257T3 (da) * 1990-07-20 2000-03-27 Bayer Ag Multimer form af human rhinovirusreceptorprotein
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
US5871733A (en) * 1990-07-20 1999-02-16 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
US5686581A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric form of human rhinovirus receptor protein
US5120830A (en) * 1990-10-25 1992-06-09 Washington University Inhibitory peptides against α-2, β-1 mediated mg++ dependent adhesion of platelets to collagen
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
CA2188287A1 (en) * 1994-04-19 1995-10-26 Stephen Benedict Icam-1/lfa-1 short-chain peptides and method of using same
US6017734A (en) * 1995-07-07 2000-01-25 The Texas A & M University System Unique nucleotide and amino acid sequence and uses thereof
US6075004A (en) * 1996-04-26 2000-06-13 The University Of Kansas Peptide compositions which induce immune tolerance and methods of use
AU4825699A (en) * 1998-06-19 2000-01-05 Genzyme Corporation Identification and use of differentially expressed genes and polynucleotide sequences
AU4971699A (en) * 1998-07-06 2000-01-24 Bai Luo Hyaluronic acid mimics and methods related thereto
PT1512695E (pt) * 2003-09-04 2009-02-16 Biomay Ag Polipéptidos hipoalergénicos à base de parvalbumina de peixe
EP1682537B1 (en) 2003-11-05 2012-03-28 SARcode Bioscience Inc. Modulators of cellular adhesion
EP2168986A3 (en) 2004-02-19 2010-07-28 Genentech, Inc. CDR-repaired antibodies
DK1881823T3 (en) 2005-05-17 2015-03-02 Sarcode Bioscience Inc COMPOSITION AND PROCEDURES FOR TREATMENT OF EYE DISORDERS
AU2008317473B2 (en) 2007-10-19 2014-07-17 Bausch + Lomb Ireland Limited Compositions and methods for treatment of diabetic retinopathy
WO2009139817A2 (en) 2008-04-15 2009-11-19 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
WO2011050175A1 (en) 2009-10-21 2011-04-28 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
WO2014018748A1 (en) 2012-07-25 2014-01-30 Sarcode Bioscience Inc. Lfa-1 inhibitor and polymorph thereof

Also Published As

Publication number Publication date
DK412589D0 (da) 1989-08-22
DE68923048D1 (de) 1995-07-20
EP0362526A3 (en) 1990-07-18
AU4014589A (en) 1990-03-01
AU634974B2 (en) 1993-03-11
ATE123810T1 (de) 1995-06-15
PT91503A (pt) 1990-03-08
NO893366D0 (no) 1989-08-22
GR3017303T3 (en) 1995-12-31
DK412589A (da) 1990-02-24
DE68923048T2 (de) 1995-11-16
FI893916A0 (fi) 1989-08-21
NO893366L (no) 1990-02-26
FI893916L (fi) 1990-02-24
EP0362526A2 (en) 1990-04-11
FI893916A7 (fi) 1990-02-24
HUT53673A (en) 1990-11-28
JPH02306999A (ja) 1990-12-20
EP0362526B1 (en) 1995-06-14
PT91503B (pt) 1996-04-30
IL91369A0 (en) 1990-04-29
IL91369A (en) 1994-08-26
KR900002796A (ko) 1990-03-23

Similar Documents

Publication Publication Date Title
ES2075016T3 (es) La subunidad alfa del receptor de adherencia a leucocitos lfa-1.
ES2077572T3 (es) Moleculas de adhesion intercelular, y sus ligandos de fijacion.
ES2058978T3 (es) Agentes de contraste para ultrasonidos, procedimiento para su preparacion y utilizacion de los mismos como agentes de diagnostico y agentes terapeuticos.
ES557016A0 (es) Procedimiento para la obtencion de celulas de hibridona que disocian anticuerpos monoclonales con elevada afinidad a la renina humana.
ES2193245T3 (es) Reactivos estables para la preparacion de radiofarmacos.
ES2086313T3 (es) Nuevos derivados de xantina con efecto antagonista de adenosina.
ES2054988T3 (es) Quinuclidinas, su empleo como medicamentos y procedimiento para su produccion.
MX146311A (es) Dispositivo intrauterino para el puerperioinmediato para el control de la fertilidad humana
BR7700253A (pt) Composicao util como um promotor de adesao para borrachas de silicone
ES2179945T3 (es) Compuestos de tetralina con actividad de resistencia a multiples farmacos.
ES2053555T3 (es) Procedimiento de ensayo y sistema de diagnostico de un marcador del metabolismo anormal de lipidos.
ES2054716T3 (es) Bis-naftalimidas, su obtencion y empleo.
PT85700A (pt) Guias curvas comandadas
ES2072251T3 (es) Composiciones y metodos para la sintesis y ensayo de enquefalinasa.
ES2073418T3 (es) Nuevos nitratos organicos y procedimiento para su preparacion.
BR8107668A (pt) Processo para a producao de compostos,bem como composicoes de vedacao e composicoes de colagem a base desses compostos
BR7604276A (pt) Membrana de cura
ES556437A0 (es) Procedimiento para preparar un agente que contiene tirosina o un derivado de tirosina como sustancia activa para mejorar la fecundidad de mamiferos.
SE7604408L (sv) Energiabsorbator
DE3877198D1 (de) Gel-zusammensetzung.
ES2070202T3 (es) Nuevos derivados de serina, procedimiento para su preparacion y su uso en terapia humana.
MX9306032A (es) Adenosinas 2-sustituidas con afinidad por el receptor a-2.
ES552462A0 (es) Dispositivo para la utilizacion de agentes decapentes en el decapado de cuerpos huecos tales como tochos, lingotes huecos o tubos
ES2036523T3 (es) 4-aminoarildihidropiridinlactonas, procedimiento para su obtencion y su empleo en medicamentos.
ES2037657T3 (es) 4-tienil-dihidropiridinas, procedimiento para su preparacion y su aplicacion en medicamentos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 362526

Country of ref document: ES